267 related articles for article (PubMed ID: 17943782)
21. Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction.
Pang R; Zhou XY; Wang X; Wang B; Yin XL; Bo H; Jung JH
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD012336. PubMed ID: 33567116
[TBL] [Abstract][Full Text] [Related]
22. Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women.
Ayeleke RO; Hay-Smith EJ; Omar MI
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010551. PubMed ID: 26526663
[TBL] [Abstract][Full Text] [Related]
23. Anticholinergic medication for antipsychotic-induced tardive dyskinesia.
Bergman H; Soares-Weiser K
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000204. PubMed ID: 29341071
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of vibegron for the treatment of overactive bladder in the United States.
Chen JV; Klein TM; Nesheim J; Mudd PN
J Med Econ; 2022; 25(1):1092-1100. PubMed ID: 35993729
[TBL] [Abstract][Full Text] [Related]
25. Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysis.
Madhuvrata P; Singh M; Hasafa Z; Abdel-Fattah M
Eur Urol; 2012 Nov; 62(5):816-30. PubMed ID: 22397851
[TBL] [Abstract][Full Text] [Related]
26. Botulinum toxin injections for adults with overactive bladder syndrome.
Duthie J; Wilson DI; Herbison GP; Wilson D
Cochrane Database Syst Rev; 2007 Jul; (3):CD005493. PubMed ID: 17636801
[TBL] [Abstract][Full Text] [Related]
27. [Anticholinergic agents for overactive bladder syndrome: current head-to-head comparison].
Goepel M; Schultz-Lampel D
Urologe A; 2011 Jul; 50(7):802-5. PubMed ID: 21681456
[TBL] [Abstract][Full Text] [Related]
28. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children.
Griffiths B; Ducharme FM
Cochrane Database Syst Rev; 2013 Aug; (8):CD000060. PubMed ID: 23966133
[TBL] [Abstract][Full Text] [Related]
29. Comparative Effectiveness of Anticholinergic Therapy for Overactive Bladder in Women: A Systematic Review and Meta-analysis.
Reynolds WS; McPheeters M; Blume J; Surawicz T; Worley K; Wang L; Hartmann K
Obstet Gynecol; 2015 Jun; 125(6):1423-1432. PubMed ID: 26000514
[TBL] [Abstract][Full Text] [Related]
30. Anticholinergic therapy for chronic asthma in children over two years of age.
McDonald NJ; Bara AI
Cochrane Database Syst Rev; 2003; 2003(3):CD003535. PubMed ID: 12917970
[TBL] [Abstract][Full Text] [Related]
31. Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women.
Ayeleke RO; Hay-Smith EJ; Omar MI
Cochrane Database Syst Rev; 2013 Nov; (11):CD010551. PubMed ID: 24259154
[TBL] [Abstract][Full Text] [Related]
32. Does anticholinergic medication have a role in treating men with overactive bladder and benign prostatic hyperplasia?
Lee KS; Lee HW; Han DH
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):491-501. PubMed ID: 18172610
[TBL] [Abstract][Full Text] [Related]
33. Non-inferior and more feasible transcutaneous tibial nerve stimulation in treating overactive bladder: A systematic review and meta-analysis.
Alomari MS; Abdulhamid AS; Ghaddaf AA; Alshareef KM; Haneef AK; AlQuhaibi MS; Banjar RA
Int J Urol; 2022 Oct; 29(10):1170-1180. PubMed ID: 35711082
[TBL] [Abstract][Full Text] [Related]
34. Flavoxate in urogynecology: an old drug revisited.
Zor M; Aydur E; Dmochowski RR
Int Urogynecol J; 2015 Jul; 26(7):959-66. PubMed ID: 25480503
[TBL] [Abstract][Full Text] [Related]
35. Bladder training for urinary incontinence in adults.
Wallace SA; Roe B; Williams K; Palmer M
Cochrane Database Syst Rev; 2004; 2004(1):CD001308. PubMed ID: 14973967
[TBL] [Abstract][Full Text] [Related]
36. Flavoxate: present and future.
Arcaniolo D; Conquy S; Tarcan T
Eur Rev Med Pharmacol Sci; 2015; 19(5):719-31. PubMed ID: 25807422
[TBL] [Abstract][Full Text] [Related]
37. Twelve-week, prospective, open-label, randomized trial on the effects of an anticholinergic agent or antidiuretic agent as add-on therapy to an alpha-blocker for lower urinary tract symptoms.
Shin YS; Zhang LT; Zhao C; Kim YG; Park JK
Clin Interv Aging; 2014; 9():1021-30. PubMed ID: 25031529
[TBL] [Abstract][Full Text] [Related]
38. Interventions for treating people with symptoms of bladder pain syndrome: a network meta-analysis.
Imamura M; Scott NW; Wallace SA; Ogah JA; Ford AA; Dubos YA; Brazzelli M
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013325. PubMed ID: 32734597
[TBL] [Abstract][Full Text] [Related]
39. No. 283-Treatments for Overactive Bladder: Focus on Pharmacotherapy.
Geoffrion R
J Obstet Gynaecol Can; 2018 Jan; 40(1):e22-e32. PubMed ID: 29274717
[TBL] [Abstract][Full Text] [Related]
40. Monotherapy with mirabegron had a better tolerance than the anticholinergic agents on overactive bladder: A systematic review and meta-analysis.
Yi W; Yang Y; Yang J
Medicine (Baltimore); 2021 Oct; 100(41):e27469. PubMed ID: 34731124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
